Talar Kachechian, DO
Sleep Medicine · Rockville, MDNPI 1386140259
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,915 of the $4,236 with a category attached, or 68.8%. ZOLL Respicardia, Inc. accounts for 70.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,078 and has fallen 94.4% since, to $173 in 2025.
Across 28 payments — averaging $151.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$3K
- Jazz Pharmaceuticals Inc.$465
- Inspire Medical Systems, Inc.$450
- Napo Pharmaceuticals Inc$125
- Axsome Therapeutics, Inc.$86
- Idorsia Pharmaceuticals US Inc$49
- plus $89 from 4 others
What the payments were for
- Consulting fees$1504%
- Travel & lodging$2,91569%
- Food & beverage$1,02424%
- Education$1473%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 5 | $2,972 |
| Jazz Pharmaceuticals Inc. | 6 | $465 |
| Inspire Medical Systems, Inc. | 5 | $450 |
| Napo Pharmaceuticals Inc | 1 | $125 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Aerin Medical Inc. | 1 | $28 |
| Harmony Biosciences LLC | 1 | $25 |
| CSL Behring | 1 | $21 |
| Theratechnologies Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$2,915
- Inspire$280
- XYWAV$272
- XYREM$150
- Mytesi$125
How this compares
$4,236 in reported general payments places this provider in the 85th percentile of 41 sleep medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 34 | $193 |
| Trazodone Hcl | 13 | $191 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Rockville
- Asefa MekonnenRockville$28K
- Pamela HowardRockville$14K
- Yash MehndirattaRockville$1K
- Sahira SekhonRockville$962
- Ritula MehndirattaRockville$273
- Syed AhmedGermantown$75K
- Konrad BakkerFrederick$8K
- Amandeep BawaBaltimore$7K
- Stephanie WappelTowson$4K
- Catherine GriffinBaltimore$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.